Skip to main content

The survey results will be included in the patient/caregiver input we will provide to Canada/Quebec’s health technology assessment agencies – e.g., CADTH and INESSS.
Survey closes: March 31, 2024

If you would like more information about the survey or our submissions regarding sotatercept, please get in touch with PHA Canada Executive Director Jamie Myrah at